Moderna to open messenger RNA vaccine factory in Australia

The project will be based at one of the country’s leading universities, Monash, and will produce 100 million doses of vaccine per year, against Covid-19, influenza and other diseases.

Article written by

Published

Update

Reading time : 1 min.

The Moderna laboratory announced on Monday August 15 the opening of a messenger RNA vaccine factory in Melbourne, Australia, a first in the southern hemisphere. The project will be based at one of the country’s leading universities, Monash, and will produce 100 million doses of vaccine per year, against Covid-19, influenza and other diseases.

Moderna’s Spikevax for the coronavirus was among the first vaccines to use new technology called messenger RNA developed during the Covid-19 pandemic.

These vaccines, which can be developed quickly, use a molecule to teach the body how to identify and fight a pathogen, such as the coronavirus, unlike traditional vaccines, which contain a small piece of bacteria or virus. Construction of the Moderna factory is due to begin this year and be completed in 2024.


source site-14

Latest